!!Bryan Paul Morgan - Curriculum Vitae \\ B. Paul Morgan, BSc, MB BCh, PhD, FRCPath, MRCP, FMedSci\\ \\ __Accreditation:__ Chemical Pathology\\Clinically active \\ \\ __Degrees, diplomas and honours:__ \\ *1977 BSc. (1st Class Hons) Medical Biochemistry. 1980 MBBCh. (Wales). 1984 PhD. (Wales) \\ *1988 Membership of the Royal College of Pathologists (MRCPath) *1997 Fellowship of the Royal College of Pathologists (FRCPath) *1999 Elected Fellow Academy of Medical Sciences (FMedSci) *2000 Elected Member Royal College of Physicians (MRCP)\\ *2001 Elected Member Association of Physicians. *2005-2008 Council Member, Academy of Medical Sciences\\ *2011- Council Member, Medical Research Council\\ \\ __National/International bodies:__ \\ *Council Member Academy of Medical Sciences (2005-2008)\\ *Member AcMedSci committee on MB PhD schemes\\ *Member AcMedSci Academic Careers Committee\\ *Member RAE 2008 sub-panel A3 (Infection and Immunity)\\ *Meetings Secretary, Treasurer, Trustee and Councillor, British Society for Immunology. International Complement Society Committee (2003-13 ); Chair 2011-2013\\ *Chair, European Complement Network (2001-2007)\\ *Chair, Grants Review Committee, NISCHR (2013 - ) \\ \\ __Current Grant support:__ \\ \\ Wellcome Trust Consortium for Neuroimmunology of Mood Disorders and Alzheimer’s Disease. 2015-2020. Value £5.7M (app. £0.5M to Cardiff). Lead for inflammatory biomarkers theme. \\ BBSRC CASE Studentship with GSK; 2015-2018; Value: app. £160,000. Title: “Signalling non-lethal effects of the membrane attack complex”.\\ MS Society Studentship 2012-2015; Value £104,350. Title: “Mechanisms and roles of microglial priming and activation in experimental demyelination and human MS”. \\ BBSRC CASE Studentship with GSK; 2012-2016; Value: app. £150,000. Title: “Mechanisms responsible for differential bactericidal activities of human and rabbit complement against Neisseria meningitidis”.\\ Fight for Sight Project Grant; 2013-2015; Value: £169,937. Title: 'The complotype as a predictor of disease and response to therapy in AMD'.\\ BHF Project Grant; 2013-2016; Value; £297,000. Title: “The role of complement dysregulation and C3adesArg in atherosclerosis".